Sträter Rechtsanwälte

What Sträter Rechtsanwälte does

Sträter Rechtsanwälte PartmbB is a Bonn-headquartered German law firm operating as a Partnerschaftsgesellschaft mit beschränkter Berufshaftung (partnership with limited professional liability), exclusively specialized in health law (Gesundheitsrecht) for Germany and the European Union. The firm is self-described as "worldwide among the leading law firms in Life Science" and serves pharmaceutical companies and medical device manufacturers navigating German and EU regulatory frameworks. Practice areas span seven service modules: product development and clinical trials (GCP, ethics committees, medical liability); EU certification and marketing authorization; intellectual property protection for pharmaceuticals (patents, SPCs, orphan and data exclusivity); distribution, competition law, and licensing; EU pharmacovigilance and product liability; the German statutory health insurance (GKV) system including G-BA early benefit assessment and AMNOG pricing; and medical device law covering classification, clinical investigations, certification, reimbursement, and advertising.

The firm's core technology is its collective human expertise rather than a software platform. The team of approximately 15 includes founder Prof. Burkhard Sträter, partners Claus Burgardt and Markus Ambrosius, and additional attorneys holding Fachanwalt für Medizinrecht specialist qualifications, doctoral degrees, and LL.M. credentials. The firm markets and acquires clients through professional publications (Streiflichter articles in PharmInd and PharmaR), a recurring educational seminar program (Sträter Kolloquien, held at Villa Godesberg in Bonn with 14–16 participants per session at EUR 495 per attendee), and a newsletter distribution channel.

The business model is a professional services model with two revenue streams: (1) legal advisory services billed to enterprise pharmaceutical and medical device clients (pricing not publicly disclosed, likely retainer or hourly), and (2) the Sträter Kolloquien seminar program generating a modest but visible secondary revenue stream at publicly disclosed per-seat pricing. The firm is independently owned by its partners, with no external investors, no parent company, no subsidiaries, and no funding rounds on record. Professional liability insurance is maintained with Allianz-Versicherungs-AG as required under §51 BRAO, and the firm is GDPR-compliant (DSGVO). The geographic footprint is Germany and the broader EU regulatory perimeter, delivered through a single Bonn office.

Name

Sträter Rechtsanwälte

Legal name

Sträter Rechtsanwälte PartmbB

Website

https://straeterlawyers.de

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Sträter Rechtsanwälte is a Bonn-based German boutique law firm with ~15 staff, exclusively specialized in health law for Germany and the EU, serving pharmaceutical and medical device companies across clinical trials, marketing authorization, IP, pharmacovigilance, GKV reimbursement, and medical device regulatory matters, supplemented by a recurring paid seminar series.

Ownership category

akta.pro rank

Product category

Legal Services — Health Law / Life Sciences

NAICS

All Other Legal Services (541199), Other Legal Services (54119)

akta.pro industry

PRIMARYHLAGAKAA

Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

SECONDARYHLAGAKAH

Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

SECONDARYHLAGALAK

Patient Support Programs & Device/Vaccine Vigilance (PSP/PSUR support)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Pharmacovigilance & Medical Affairs Services

Keywords

• Pharmaceutical regulatory law
• Medical device law
• EU health law advisory
• Pharmacovigilance compliance
• Statutory health insurance law

Headquarters

HQ city

Bonn

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

1. Legal Advisory Services: Professional legal services in health law, pharmaceutical law, and medical device regulatory matters. Revenue generated through attorney fees for legal counsel, representation, and advisory services to pharmaceutical and medical device companies.
2. Seminars and Training (Sträter Kolloquien): The firm conducts regular seminar programs (Sträter Kolloquien) at the Villa Godesberg in Bonn, targeting legal departments and regulatory professionals in pharmaceutical and medical device companies. Each seminar is priced at EUR 495.00 with limited participation (14-16 attendees).

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Sträter Rechtsanwälte provides specialized legal advisory and representation services in health law (Gesundheitsrecht) for Germany and the European Union, serving pharmaceutical and medical device companies. Core practice areas include clinical trials and product development, EU certification and marketing authorization, IP protection for pharmaceuticals, distribution/competition/licensing, pharmacovigilance and product liability, statutory health insurance (GKV) reimbursement, and medical device regulation. The firm also operates the Sträter Kolloquien seminar series priced at EUR 495 per participant.

Product overview

Sträter Rechtsanwälte is a law firm offering specialised legal services in health law (Gesundheitsrecht) for the Federal Republic of Germany and the European Union. The firm's portfolio centers on advisory and representation for pharmaceutical products and medical devices. The core offering is complemented by seven specialised service modules covering product development and clinical trials, EU certification and marketing authorisation, intellectual property protection for pharmaceuticals, distribution and competition law, pharmacovigilance and product liability, the statutory health insurance system (GKV), and medical devices law. Additionally, the firm offers the Sträter Kolloquien, a series of educational seminars and colloquia on current topics in health law, conducted in an intensive format with limited participants.

Differentiator

Problem solved

Functional benefit

Products and services

• Gesundheitsrecht (Health Law Services)
• Sträter Kolloquien

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Direct peers

• Linklaters: Global magic-circle firm with a German life sciences regulatory practice anchored in Frankfurt. Overlaps with Sträter on EU pharma regulatory, IP, and competition law mandates for enterprise pharma clients.
• CMS Germany: Major European firm with a sizable German healthcare and pharmaceuticals practice. Competes with Sträter on regulatory, GKV reimbursement, and product liability work for German and EU pharma clients.
• Covington & Burling: US-based firm globally renowned for pharma, biotech and medical device regulatory practice with strong EU coverage. Comparable to Sträter in specialty pharma regulatory depth and target clients.
• Osborne Clarke Germany: International firm with a focused Germany-based Life Sciences practice, particularly strong in medical devices, digital health, and regulatory matters. Closely comparable to Sträter in scope and target client mix.
• Taylor Wessing: European-headquartered international firm with a recognized Life Sciences & Healthcare group in Germany. Competes with Sträter for German pharma and medtech regulatory mandates while offering broader corporate/IP capabilities.
• Allen & Overy Germany (A&O Shearman): Major international firm with a German life sciences/IP practice post the Shearman merger. Competes for enterprise pharma regulatory, transactional and IP mandates that overlap with Sträter's niche.
• Bird & Bird: International law firm with one of Europe's strongest dedicated Life Sciences regulatory practices across Germany, UK and the EU. Directly competes with Sträter on pharma regulatory, medical device, and IP mandates for pharma and medtech clients in Germany and the EU.
• Clifford Chance Germany: Global magic-circle firm with a Frankfurt-based healthcare and life sciences practice. Overlaps with Sträter on cross-border pharma regulatory and product liability mandates for large pharma.
• Hengeler Mueller: Premier German full-service firm with a leading healthcare and life sciences practice. Competes with Sträter for top-tier German pharma regulatory, antitrust, and corporate matters, though it serves a broader practice mix.
• Baker McKenzie Germany: Global firm with a significant German healthcare and life sciences practice in Frankfurt. Overlaps with Sträter on pharma regulatory, IP, and cross-border mandates for enterprise clients.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/str%C3%A4ter-rechtsanw%C3%A4lte

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sträter Rechtsanwälte